Finance

Lists
3371:FRA
Corbus Pharmaceuticals Holdings Inc
€8.14
+1.56%
(+0.12) 1D
Aug 7, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 3371...
Open
€8.14
High
€8.14
Low
€8.14
Mkt. cap
188.43M
Avg. vol.
80.00
Volume
0.00
52-wk high
€18.40
52-wk low
€5.80
No. of employees
36
Open
€8.14
High
€8.14
Low
€8.14
Mkt. cap
188.43M
Avg. vol.
80.00
Volume
0.00
52-wk high
€18.40
52-wk low
€5.80
No. of employees
36
News stories
From sources across the web
About Corbus Pharmaceuticals Holdings Inc
CEO-
Employees36
FoundedJan 1, 2009
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
15.19M
20.86M
18.41M
19.82M
Cost of revenue
15.19M
20.86M
18.41M
19.82M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.96M
3.56M
3.56M
4.48M
Operating expense
3.96M
3.56M
3.56M
4.48M
Total operating expenses
19.15M
24.42M
21.97M
24.30M
Operating income
-19.15M
-24.42M
-21.97M
-24.30M
Other non operating income
176.00K
-50.00K
-1.10M
-67.00K
EBT including unusual items
-17.66M
-23.34M
-20.56M
-22.97M
EBT excluding unusual items
-17.66M
-23.34M
-21.66M
-22.97M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.66M
-23.34M
-20.56M
-22.97M
Net profit margin
-
-
-
-
Earnings per share
-1.44
-1.90
-1.25
-1.23
Interest and investment income
1.31M
1.12M
1.41M
1.40M
Interest expense
-
-
-
-
Net interest expenses
1.31M
1.12M
1.41M
1.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
-19.10M
-24.37M
-21.92M
-24.26M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps